REBECCA BRAUNER: Open Payments
NPI 1871526970 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,826 in 31 payments from 9 companies in 2025. Trend: 2023 $2,001 · 2024 $16,221 · 2025 $7,826
Speaker / faculty: $5,300Food & beverage: $1,814Consulting: $475Travel & lodging: $237
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $5,998 |
| Verona Pharma, Inc. | 6 | $853 |
| Actelion Pharmaceuticals US, Inc. | 3 | $281 |
| Insmed, Inc. | 1 | $137 |
| GENZYME CORPORATION | 1 | $120 |
| JAZZ PHARMACEUTICALS INC. | 1 | $118 |
| PFIZER INC. | 1 | $111 |
| Merck Sharp & Dohme LLC | 1 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $101 |
Products named: BREZTRI, Ohtuvayre, UPTRAVI, Arikayce, TEZSPIRE, DUPIXENT, XYWAV, PREVNAR 20.
Industry payments across KY — which companies pay providers there.
